合成路线1
该中间体在本合成路线中的序号:
(VI) Horner-Emmons condensation of 1-benzyl-4-piperidone (VI) with phosphonate (IV) furnished the unsaturated ester (VII). Hydrogenation of (VII) over Pd/C produced double bond reduction and simultaneous N-benzyl group cleavage to afford piperidine (VIII). This was finally alkylated with chloride (I) in the presence of K2CO3 and NaI.
【1】
Buzas, A.; Merour, J.-Y.; Ollivier, R. (Laboratoires Meram SA); Benzhydryloxyethylpiperidine derivs., process for their preparation and pharmaceutical compsns., in which they are present. EP 0259227; US 4983614 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34744 |
1-[(2-chloroethoxy)(phenyl)methyl]benzene; benzhydryl 2-chloroethyl ether
|
32669-06-0 |
C15H15ClO |
详情 | 详情
|
(IV) |
10019 |
Ethyl 2-(diethoxyphosphoryl)acetate; Triethyl phosphonoacetate
|
867-13-0 |
C8H17O5P |
详情 | 详情
|
(VI) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(VII) |
34747 |
ethyl 2-(1-benzyl-4-piperidinylidene)acetate
|
|
C16H21NO2 |
详情 |
详情
|
(VIII) |
28087 |
4-Piperidineacetic acid ethyl ester; ethyl 2-(4-piperidinyl)acetate
|
|
C9H17NO2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(VII) Horner-Emmons condensation of 1-benzyl-4-piperidone (VII) with phosphonate (IV) furnished the unsaturated ester (VIII). Hydrogenation of (VIII) over Pd/C produced double bond reduction and simultaneous N-benzyl group cleavage to afford piperidine (IX). This was finally alkylated with chloride (I) in the presence of K2CO3 and NaI and hydrolyzed to target compound.
【1】
Buzas, A.; Merour, J.-Y.; Ollivier, R. (Laboratoires Meram SA); Benzhydryloxyethylpiperidine derivs., process for their preparation and pharmaceutical compsns., in which they are present. EP 0259227; US 4983614 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34744 |
1-[(2-chloroethoxy)(phenyl)methyl]benzene; benzhydryl 2-chloroethyl ether
|
32669-06-0 |
C15H15ClO |
详情 | 详情
|
(IV) |
10019 |
Ethyl 2-(diethoxyphosphoryl)acetate; Triethyl phosphonoacetate
|
867-13-0 |
C8H17O5P |
详情 | 详情
|
(VI) |
34748 |
ethyl 2-[1-[2-(benzhydryloxy)ethyl]-4-piperidinyl]acetate
|
|
C24H31NO3 |
详情 |
详情
|
(VII) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(VIII) |
34747 |
ethyl 2-(1-benzyl-4-piperidinylidene)acetate
|
|
C16H21NO2 |
详情 |
详情
|
(IX) |
28087 |
4-Piperidineacetic acid ethyl ester; ethyl 2-(4-piperidinyl)acetate
|
|
C9H17NO2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) The reaction of 1-benzyl-4-piperidone (I) with aniline (II) and KCN in acetic acid gives the aminonitrile (III), which is treated with H2SO4 at room temperature to yield the carboxamide (IV). The hydrolysis of (IV) with refluxing aqueous HCl affords the carboxylic acid (V), which is esterified with Ms-OH and methanol to provide the methyl ester (VI). Acylation of the NH group of (VI) with propionic anhydride (VII) gives the propionamide (VIII), which is debenzylated with H2 over Pd/C to yield the piperidine (IX). Finally, this compound is condensed with methyl acrylate (XI) in acetonitrile to afford the target compound.
【1】
Killgore, J.K.; Jacob, M. (Mallinckrodt Medical Inc.); New methods for the syntheses of alfentanil, sufentanil and remifentanil. WO 0140184 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
(III) |
49674 |
4-Anilino-1-benzyl-4-cyanopiperidine
|
|
C19H21N3 |
详情 |
详情
|
(IV) |
49675 |
4-Anilino-1-benzylisonipecotamide
|
|
C19H23N3O |
详情 |
详情
|
(V) |
33884 |
4-anilino-1-benzyl-4-piperidinecarboxylic acid
|
|
C19H22N2O2 |
详情 |
详情
|
(VI) |
49676 |
methyl 4-anilino-1-benzyl-4-piperidinecarboxylate
|
|
C20H24N2O2 |
详情 |
详情
|
(VII) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(VIII) |
49677 |
methyl 1-benzyl-4-(propionylanilino)-4-piperidinecarboxylate
|
|
C23H28N2O3 |
详情 |
详情
|
(IX) |
15668 |
methyl 4-(propionylanilino)-4-piperidinecarboxylate
|
|
C16H22N2O3 |
详情 |
详情
|
(X) |
14156 |
methyl acrylate
|
96-33-3 |
C4H6O2 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) N-Benzyl-4-piperidone (I) was reacted with a Grignard reagent prepared from 4-fluorobromobenzene (II) to give the carbinol (III). The benzyl group was removed by catalytic hydrogenation and the resulting amine (IV) was alkylated with 3-bromopropionaldehyde ethylene acetal (V) to the alcohol (VI). Ring closure in hydrochloric acid gave the bicyclic endo-alcohol [(±)-VII] along with some of the exo-isomer removed by crystallization. [(±)-VII] was resolved by crystallization with (R,R)-tartaric acid mono-4-chloroanilide (VIII) to give [(+)-VII] of yet unknown absolute configuration. The latter was acylated with propionic anhydride followed by crystallization with hydrogen chloride in ether to furnish the end product.
【1】
Sólyom, S.; Abraham, G.; Szölössy, M.; Borsi, J.; Vitális, B.; Karimné Tapfer, M.; Szabóné Bady, E.; Csuzdi, E.; Goldschmidtné Horváth, K.; Máté, G.; Ling, I.; Miklósné Kovács, A. (Gyogyszerkutato Intezet Kft.); New 1-azabicycloalkane derivs., pharmaceutical compsns. containing them and process for preparing same. EP 0556342; JP 1994505706; WO 9207854 . |
【2】
Nogradi, M.; GYKI-46903. Drugs Fut 1993, 18, 5, 421.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
((+/-)-VII |
15726 |
(rac)-[(4R*,5S*)-6-(4-fluorophenyl)-1-azabicyclo[3.3.1]non-6-en-4-ol]
|
|
C14H16FNO |
详情 |
详情
|
((R,R)-VII) |
15727 |
(2R,3R)-4-(4-chloroanilino)-2,3-dihydroxy-4-oxobutyric acid
|
|
C10H10ClNO5 |
详情 |
详情
|
((+)-VII) |
64680 |
(4R,5S)-6-(4-fluorophenyl)-1-azabicyclo[3.3.1]non-6-en-4-ol
|
|
C14H16FNO |
详情 |
详情
|
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
13643 |
4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide |
352-13-6 |
C6H4BrFMg |
详情 | 详情
|
(III) |
15722 |
1-benzyl-4-(4-fluorophenyl)-4-piperidinol
|
|
C18H20FNO |
详情 |
详情
|
(IV) |
15723 |
4-(4-fluorophenyl)-4-piperidinol; 4-(4-Fluorophenyl)-4-hydroxypiperidine
|
3888-65-1 |
C11H14FNO |
详情 | 详情
|
(V) |
15724 |
2-(2-bromoethyl)-1,3-dioxolane
|
18742-02-4 |
C5H9BrO2 |
详情 | 详情
|
(VI) |
15725 |
1-[2-(1,3-dioxolan-2-yl)ethyl]-4-(4-fluorophenyl)-4-piperidinol
|
|
C16H22FNO3 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) Protected piperidone (I) is condensed with methoxybromobenzene (II) via Grignard reaction by means of Mg and catalytic iodine in refluxing THF, and the resulting alcohol is then dehydrated with refluxing HCl in dioxane to afford compound (III). Hydrogenation of tetrahydropyridine (III) over Pd/C in EtOH yields piperidine derivative (IV), which is then demethylated with aqueous HBr to provide phenol (V). Condensation of (V) with 4-fluorobenzoyl chloride (VI) by means of NaOH in iPrOH/MeOH/H2O furnishes N-benzoylpiperidine derivative (VII), which is converted into the desired product by reaction with ethyl 2-bromo-2-methylpropanoate (VIII) by means of K2CO3 followed by hydrolysis with NaOH in H2O/MeOH/dioxane.
【1】
Komoto, T.; et al.; Preparation of new fibrates with piperidine ring and the pharmacological activity. 20th Symp Med Chem (Dec 6 2000, Tokyo) 2000, Abst 2P-06.
|
【2】
Komoto, T.; et al.; New strong fibrates with piperidine moiety. Chem Pharm Bull 2000, 48, 12, 1978.
|
【3】
Komoto, T.; Hirota, H.; Sato, S.; Othsuka, M.; Koya, H.; Mizuno, H.; Kuraishi, T. (SSP Co., Ltd.); Arylamide derivs.. EP 0607536; JP 1995053517; US 5411972 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
35983 |
m-bromoanisole; 1-Bromo-3-methoxybenzene; 3-Bromoanisole; 3-Bromophenyl methyl ether
|
2398-37-0 |
C7H7BrO |
详情 | 详情
|
(III) |
47137 |
1-benzyl-4-(3-methoxyphenyl)-1,2,3,6-tetrahydropyridine; 3-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)phenyl methyl ether
|
|
C19H21NO |
详情 |
详情
|
(IV) |
47138 |
4-(3-methoxyphenyl)piperidine; methyl 3-(4-piperidinyl)phenyl ether
|
|
C12H17NO |
详情 |
详情
|
(V) |
47139 |
3-(4-piperidinyl)phenol
|
|
C11H15NO |
详情 |
详情
|
(VI) |
17263 |
4-fluorobenzoyl chloride
|
403-43-0 |
C7H4ClFO |
详情 | 详情
|
(VII) |
47140 |
(4-fluorophenyl)[4-(3-hydroxyphenyl)-1-piperidinyl]methanone
|
|
C18H18FNO2 |
详情 |
详情
|
(VIII) |
39799 |
ethyl 2-bromo-2-methylpropanoate
|
600-00-0 |
C6H11BrO2 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) N-Benzyl-4-hydroxy-4-phenylpiperidine (II) was prepared by addition of phenyllithium to N-benzyl-4-piperidone (I). Carbinol (II) was then converted to acetamide (III) by acid-catalyzed Ritter reaction with acetonitrile. Replacement of the acetamido for an N-Boc group in (III) was effected by acidic hydrolysis of amide (III) to give (IV), followed by treatment with di-tert-butyl dicarbonate. The resultant 1-benzyl-4-(Boc-amino)-4-phenylpiperidine (V) was subjected to catalytic hydrogenolysis in the presence of Pd/C, and the N-debenzylated piperidine (VI) was reprotected as the N-trityl derivative (VII) by treatment with triphenylmethyl chloride and triethylamine. Reduction of the N-Boc group of (VII) by LiAlH4, yielded the N-methyl amine (VIII). After acylation of (VIII) with acetyl chloride to acetamide (IX), its N-trityl group was cleaved by treatment with hot aqueous formic acid to produce the intermediate piperidine (X).
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
29470 |
1-benzyl-4-phenyl-4-piperidinol
|
|
C18H21NO |
详情 |
详情
|
(III) |
54993 |
N-(1-benzyl-4-phenyl-4-piperidinyl)acetamide
|
|
C20H24N2O |
详情 |
详情
|
(IV) |
54994 |
1-benzyl-4-phenyl-4-piperidinylamine; 1-benzyl-4-phenyl-4-piperidinamine
|
|
C18H22N2 |
详情 |
详情
|
(V) |
59263 |
tert-butyl 1-benzyl-4-phenyl-4-piperidinylcarbamate
|
|
C23H30N2O2 |
详情 |
详情
|
(VI) |
54998 |
tert-butyl 4-phenyl-4-piperidinylcarbamate
|
|
C16H24N2O2 |
详情 |
详情
|
(VII) |
59264 |
tert-butyl 4-phenyl-1-trityl-4-piperidinylcarbamate
|
|
C35H38N2O2 |
详情 |
详情
|
(VIII) |
59265 |
N-methyl-4-phenyl-1-trityl-4-piperidinamine; N-methyl-N-(4-phenyl-1-trityl-4-piperidinyl)amine
|
|
C31H32N2 |
详情 |
详情
|
(IX) |
59266 |
N-methyl-N-(4-phenyl-1-trityl-4-piperidinyl)acetamide
|
|
C33H34N2O |
详情 |
详情
|
(X) |
59267 |
N-methyl-N-(4-phenyl-4-piperidinyl)acetamide
|
|
C14H20N2O |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) The condensation of 1-benzylpiperidin-4-one (I) with 4-acetamidoacetophenone (II) by means of lithium diisopropylamide in HMPA/THF gives the piperidinol (III), which is dehydrated by reaction first with SOCl2 and then with NaOH yielding a mixture of compounds (IV) and (V) with exo and endo double bonds. This mixture is hydrogenated with H2 over PtO2 in ethanol/toluene to afford the saturated piperidine derivative (VI), which is treated with HCl in refluxing ethanol to cleave the acetamido substituent giving (VII) with a free amino group. Finally, this compound is condensed with 4-chloro-5-methylpyrimidine (VIII) by means of HCl in refluxing ethanol/CHCl3.
【1】
Kimura, T.; Kuroki, Y.; Fujiwara, H.; Anpeiji, S. (Ube Industries, Ltd.); Pyrimidine cpd.. EP 0664291; WO 9407890 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
26414 |
N-(4-acetylphenyl)acetamide
|
2719-21-3 |
C10H11NO2 |
详情 | 详情
|
(III) |
26415 |
N-[4-[2-(1-benzyl-4-hydroxy-4-piperidinyl)acetyl]phenyl]acetamide
|
|
C22H26N2O3 |
详情 |
详情
|
(IV) |
26416 |
N-[4-[2-(1-benzyl-4-piperidinylidene)acetyl]phenyl]acetamide
|
|
C22H24N2O2 |
详情 |
详情
|
(V) |
26417 |
N-[4-[2-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)acetyl]phenyl]acetamide
|
|
C22H24N2O2 |
详情 |
详情
|
(VI) |
26418 |
N-[4-[2-(1-benzyl-4-piperidinyl)acetyl]phenyl]acetamide
|
|
C22H26N2O2 |
详情 |
详情
|
(VII) |
26419 |
1-(4-aminophenyl)-2-(1-benzyl-4-piperidinyl)-1-ethanone
|
|
C20H24N2O |
详情 |
详情
|
(VIII) |
26420 |
4-chloro-5-methylpyrimidine
|
|
C5H5ClN2 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(V) In an alternative procedure, lithiation of 4-(benzyloxy)-1-bromobenzene (IV), followed by addition of 1-benzyl-4-piperidone (V), gave piperidinol (VI). Subsequent treatment of (VI) with HCl produced dehydration of the tertiary alcohol and benzyl ether cleavage to give (VII). Double bond reduction and hydrogenolysis of the N-benzyl group of (VII) with H2 over Pd/C gave 4-(4-hydroxyphenyl)piperidine (VIII). This was finally alkylated with tosylate (II) to yield the title compound.
【1】
Guzikowski, A.P.; Acosta-Burruel, M.; Tamiz, A.P.; et al.; Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (±)-3-(4-hydroxyphenyl)pyrrolidines: Selective antagonists at the 1A/2B NMDA receptor subtype. J Med Chem 2000, 43, 5, 984. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
43154 |
4-phenylbutyl 4-methylbenzenesulfonate
|
|
C17H20O3S |
详情 |
详情
|
(IV) |
43156 |
1-(benzyloxy)-4-bromobenzene; benzyl 4-bromophenyl ether
|
6793-92-6 |
C13H11BrO |
详情 | 详情
|
(V) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(VI) |
43157 |
1-benzyl-4-[4-(benzyloxy)phenyl]-4-piperidinol
|
|
C25H27NO2 |
详情 |
详情
|
(VII) |
43158 |
4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)phenol
|
|
C18H19NO |
详情 |
详情
|
(VIII) |
43159 |
4-(4-piperidinyl)phenol
|
|
C11H15NO |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) Condensation of N-benzyl-4-piperidinone (I) with phenethylamine (II) produced the corresponding imine (III), which was subsequently reduced to amine (IV) using NaBH4. Schweiler-Clarke methylation of the secondary amine (IV) in the presence of formaldehyde and formic acid gave (V). The N-benzyl protecting group of (V) was then removed by catalytic hydrogenation, yielding piperidine (VI). This was finally coupled with 3,5-dimethyl-4-propionamidobenzoic acid (VII) by means of diethyl cyanophosphate to produce the target compound, which was isolated as the hydrochloride salt.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
18333 |
Phenethylamine; 2-Phenyl-1-ethanamine
|
64-04-0 |
C8H11N |
详情 | 详情
|
(III) |
55870 |
N-(1-benzyl-4-piperidinylidene)-N-phenethylamine; N-(1-benzyl-4-piperidinylidene)-2-phenyl-1-ethanamine
|
|
C20H24N2 |
详情 |
详情
|
(IV) |
55871 |
N-(1-benzyl-4-piperidinyl)-N-phenethylamine; 1-benzyl-N-phenethyl-4-piperidinamine
|
|
C20H26N2 |
详情 |
详情
|
(V) |
55872 |
N-(1-benzyl-4-piperidinyl)-N-methyl-N-phenethylamine; 1-benzyl-N-methyl-N-phenethyl-4-piperidinamine
|
|
C21H28N2 |
详情 |
详情
|
(VI) |
55873 |
N-methyl-N-phenethyl-N-(4-piperidinyl)amine; N-methyl-N-phenethyl-4-piperidinamine
|
|
C14H22N2 |
详情 |
详情
|
(VII) |
55874 |
3,5-dimethyl-4-(propionylamino)benzoic acid
|
|
C12H15NO3 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(III) The Grignard reagent (II), prepared form 4-methylbenzyl chloride (I), was condensed to N-benzyl-4-piperidone (III) in cold THF to provide the 4-hydroxy-4-benzylpiperidine (IV). Catalytic hydrogenolysis of the N-benzyl group of (IV) over Pd/C gave piperidine (V), which was then alkylated with 2-(4-benzyloxyphenoxy)ethyl bromide (VI) in refluxing acetonitrile to afford (VII). The O-benzyl group of (VII) was finally cleaved by hydrogenolysis in the presence of Pd(OH)2 to furnish the target compound.
【1】
Zhou, Z.-L.; et al.; Synthesis and SAR of 4-benzyl-4-hydroxy-N-(hydroxy. 216th ACS Natl Meet (Aug. 23-27, Boston) 1998, Abst MEDI 114.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22166 |
1-(chloromethyl)-4-methylbenzene
|
104-82-5 |
C8H9Cl |
详情 | 详情
|
(II) |
22167 |
chloro(4-methylbenzyl)magnesium
|
|
C8H9ClMg |
详情 |
详情
|
(III) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(IV) |
22169 |
1-benzyl-4-(4-methylbenzyl)-4-piperidinol
|
|
C20H25NO |
详情 |
详情
|
(V) |
22170 |
4-(4-methylbenzyl)-4-piperidinol
|
|
C13H19NO |
详情 |
详情
|
(VI) |
22171 |
1-(benzyloxy)-4-(2-bromoethoxy)benzene; benzyl 4-(2-bromoethoxy)phenyl ether
|
|
C15H15BrO2 |
详情 |
详情
|
(VII) |
22172 |
1-[2-[4-(benzyloxy)phenoxy]ethyl]-4-(4-methylbenzyl)-4-piperidinol
|
|
C28H33NO3 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(I) The title compound is prepared by two related methods. N-Benzyl-4-piperidone (I) is condensed with KCN and MeNH2.HCl to produce amino nitrile (II). Partial hydrolysis of nitrile (II) with H2SO4 furnishes amide (III). Condensation of the amino amide (III) with triethyl orthoformate gives rise to the spiro imidazolinone (IV). Catalytic hydrogenation of the imidazoline double bond of (IV) and simultaneous N-benzyl group hydrogenolysis gives rise to 1-methyl-1,3,8-triazaspiro[4,5]decan-4-one (V). This is finally alkylated with 4'-fluoro-4-chlorobutyrophenone (VI) to yield the desired compound (1,2).
【1】
Metwally, K.A.; Dukat, M.; Egan, C.T.; Smith, C.; Dupre, A.; Gauthier, C.B.; Herrick-Davis, K.; Teitler, M.; Glennon, R.A.; Spiperone: Influence of spiro ring substituents on 5-HT2A serotonin receptor binding. J Med Chem 1998, 41, 25, 5084.
|
【2】
Janssen, P.A.J. (Janssen Pharmaceutica NV); 2,4,8-Triaza-spiro(4,5)dec-2-enes. US 3155669 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
64576 |
1-benzyl-4-(methylamino)-4-piperidinecarbonitrile
|
|
C14H19N3 |
详情 |
详情
|
(III) |
22019 |
1-benzyl-4-(methylamino)-4-piperidinecarboxamide
|
1024-11-9 |
C14H21N3O |
详情 | 详情
|
(IV) |
64577 |
8-benzyl-1-methyl-1,3,8-triazaspiro[4.5]dec-2-en-4-one
|
|
C15H19N3O |
详情 |
详情
|
(V) |
64578 |
1-methyl-1,3,8-triazaspiro[4.5]decan-4-one
|
|
C8H15N3O |
详情 |
详情
|
(VI) |
35864 |
4-chloro-1-(4-fluorophenyl)-1-butanone
|
3874-54-2 |
C10H10ClFO |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(I) Similarly, the condensation of N-benzyl-4-piperidone (I) with KCN in the presence of NH4Cl provides amino nitrile (II), which is further hydrolyzed to amide (III) with 95% H2SO4. Cyclization of amino amide (III) with formamide under acidic conditions yields the spiro imidazolinone (IV), which is further reduced to imidazolidinone (V) employing NaBH4 in hot MeOH. Debenzylation of (V) with H2 and Pd/C provides 1,3,8-triazaspiro[4,5]decan-4-one (VI). Then, alkylation of (VI) with 4'-fluoro-4-chlorobutyrophenone (VII) by means of K2CO3 and catalytic KI in methyl isobutyl ketone furnishes (VIII). The imidazolidinone ring of (VIII) is finally methylated with iodomethane and KOH to produce the title compound (2).
【1】
Metwally, K.A.; Dukat, M.; Egan, C.T.; Smith, C.; Dupre, A.; Gauthier, C.B.; Herrick-Davis, K.; Teitler, M.; Glennon, R.A.; Spiperone: Influence of spiro ring substituents on 5-HT2A serotonin receptor binding. J Med Chem 1998, 41, 25, 5084.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
64579 |
4-amino-1-benzyl-4-piperidinecarbonitrile
|
|
C13H17N3 |
详情 |
详情
|
(III) |
64580 |
4-amino-1-benzyl-4-piperidinecarboxamide
|
|
C13H19N3O |
详情 |
详情
|
(IV) |
64581 |
8-benzyl-1,3,8-triazaspiro[4.5]dec-2-en-4-one
|
|
C14H17N3O |
详情 |
详情
|
(V) |
64582 |
8-benzyl-1,3,8-triazaspiro[4.5]decan-4-one
|
|
C14H19N3O |
详情 |
详情
|
(VI) |
64583 |
1,3,8-triazaspiro[4.5]decan-4-one
|
|
C7H13N3O |
详情 |
详情
|
(VII) |
35864 |
4-chloro-1-(4-fluorophenyl)-1-butanone
|
3874-54-2 |
C10H10ClFO |
详情 | 详情
|
(VIII) |
64584 |
8-[4-(4-fluorophenyl)-4-oxobutyl]-1,3,8-triazaspiro[4.5]decan-4-one
|
|
C17H22FN3O2 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(XVI) The protection of 3-bromo-1-propanol (I) with dihydropyran (DHP) and p-toluenesulfonic acid gives the tetrahydropyranyl ether (II), which is condensed with 3,4-dichlorophenylacetonitrile (III) by means of NaH in THF yielding the pentanenitrile (IV). The condensation of (IV) with ethyl 3-bromopropionate (V) by means of potassium hexamethyldisylazide (KHMDS) in THF affords the heptanoate (VI), which is reductocyclized with H2 over RaNi in ethanol/aq. NH4OH affording the piperidone (VII). The reduction of (VII) by means of LiAlH4 in THF gives the piperidine (VIII), which is deprotected with HCl in ethyl ether yielding the racemic propanol (IX). The optical resolution of (IX) by means of (+)-camphorsulfonic acid in isopropanol affords the desired enantiomer (X), which is acylated with benzoyl chloride (XI) and DIEA in dichloromethane providing the benzoylpiperidine (XII). The reaction of (XII) with methanesulfonyl chloride and triethylamine gives the mesylate (XIII), which is treated with KI in refluxing acetone to yield the 3-iodopropyl derivative (XIV). Finally, (XIV) is condensed with 4-hydroxy-4-phenylpiperidine (XV) by means of KHCO3 in hot acetonitrile.
The intermediate 4-hydroxy-4-phenylpiperidine (XV) has been obtained as follows: The reaction of 1-benzyl-4-piperidone (XVI) with phenyllithium in THF gives 1-benzyl-4-hydroxy-4-phenylpiperidine (XVII), which is then debenzy-lated by hydrogenation with H2.
【1】
Kuo, B.-S.; Lee, H.T.; Roth, B.D.; Chung, F.-Z.; Atherton, J.; Chen, M.H.; Syntheses and biological activities of chiral piperidines-tachykinin NK3 antagonists. Acta Pharm Sin 1999, 20, 3, 283.
|
【2】
Chen, M.H.G.; Lee, H.T.; Chung, F.-Z. (Pfizer Inc.); 3-Alkyl-3-phenyl-piperidines. WO 9811090 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12573 |
3-Bromo-1-propanol; 3-Bromopropanol
|
627-18-9 |
C3H7BrO |
详情 | 详情
|
(II) |
29460 |
2-(4-bromobutoxy)tetrahydro-2H-pyran; 4-bromobutyl tetrahydro-2H-pyran-2-yl ether
|
|
C9H17BrO2 |
详情 |
详情
|
(III) |
26935 |
2-(3,4-dichlorophenyl)acetonitrile
|
3218-49-3 |
C8H5Cl2N |
详情 | 详情
|
(IV) |
29461 |
2-(3,4-dichlorophenyl)-6-(tetrahydro-2H-pyran-2-yloxy)hexanenitrile
|
|
C17H21Cl2NO2 |
详情 |
详情
|
(V) |
29132 |
ethyl 3-bromopropanoate
|
539-74-2 |
C5H9BrO2 |
详情 | 详情
|
(VI) |
29462 |
ethyl 4-cyano-4-(3,4-dichlorophenyl)-8-(tetrahydro-2H-pyran-2-yloxy)octanoate
|
|
C22H29Cl2NO4 |
详情 |
详情
|
(VII) |
29463 |
5-(3,4-dichlorophenyl)-5-[4-(tetrahydro-2H-pyran-2-yloxy)butyl]-2-piperidinone
|
|
C20H27Cl2NO3 |
详情 |
详情
|
(VIII) |
29464 |
3-(3,4-dichlorophenyl)-3-[4-(tetrahydro-2H-pyran-2-yloxy)butyl]piperidine; 4-[3-(3,4-dichlorophenyl)-3-piperidinyl]butyl tetrahydro-2H-pyran-2-yl ether
|
|
C20H29Cl2NO2 |
详情 |
详情
|
(IX) |
29465 |
3-[3-(3,4-dichlorophenyl)-3-piperidinyl]-1-propanol
|
|
C14H19Cl2NO |
详情 |
详情
|
(X) |
29466 |
3-[(3S)-3-(3,4-dichlorophenyl)piperidinyl]-1-propanol
|
|
C14H19Cl2NO |
详情 |
详情
|
(XI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XII) |
29467 |
[(3S)-3-(3,4-dichlorophenyl)-3-(3-hydroxypropyl)piperidinyl](phenyl)methanone
|
|
C21H23Cl2NO2 |
详情 |
详情
|
(XIII) |
29468 |
3-[(3S)-1-benzoyl-3-(3,4-dichlorophenyl)piperidinyl]propyl methanesulfonate
|
|
C22H25Cl2NO4S |
详情 |
详情
|
(XIV) |
29469 |
[(3S)-3-(3,4-dichlorophenyl)-3-(3-iodopropyl)piperidinyl](phenyl)methanone
|
|
C21H22Cl2INO |
详情 |
详情
|
(XV) |
28021 |
4-phenyl-4-piperidinol; 4-Hydroxy-4-phenylpiperidine; 4-(4-Phenyl)-4-hydroxypiperidine
|
40807-61-2 |
C11H15NO |
详情 | 详情
|
(XVI) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(XVII) |
24014 |
Phenyllithium
|
591-51-5 |
C6H5Li |
详情 | 详情
|
(XVIII) |
29470 |
1-benzyl-4-phenyl-4-piperidinol
|
|
C18H21NO |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(I) The condensation of 1-benzyl-4-piperidone (I) with 4-iodoanisole (II) in ethyl ether gives 1-benzyl-4-(2-methoxyphenyl)piperidin-4-ol (III), which is dehydrated by means of p-toluenesulfonic acid in refluxing toluene yielding the tetrahydropyridine (IV). The hydroboration of (IV) with NaBH4 and BF3 ethearate in dimethoxyethane affords trans-1-benzyl-4-(2-methoxyphenyl)piperidin-3-ol (V), which is treated with BBr3 in dichloromethane to give the 4-hydroxyphenyl derivative (VI). The hydrogenolysis of (VI) with H2 over Pd/C in methanol yields trans-4-(2-hydroxyphenyl)piperidin-3-ol (VII), which is treated with tert-butoxycarbonyl anhydride and triethylamine in DMF to afford the carbamate (VIII). The condensation of 3-chloropropyl-(2-methoxyphenyl)ether (IX) (obtained by the NaH promoted condensation of 2-methoxybenzyl chloride (X) and 3-chloropropanol (XI)) with (VIII) by means of K2CO3 in hot 2-butanone gives the expected phenolic ether (XII), which is condensed with 7-(bromomethyl)quinoline (XIII) by means of NaH in DMF yielding the piperidinyl ether (XIV). The selective hydrogenation of (XIV) with NiCl2 and NaBH4 in methanol affords the tetrahydroquinoline derivative (XV), which is finally treated with HCl in methanol to eliminate the carbamate protecting group.
【1】
Breu, V.; Guller, R.; Binggeli, A.; et al.; Piperidine-renin inhibitors compounds with improved physicochemical properties. Bioorg Med Chem Lett 1999, 9, 10, 1403.
|
【2】
Binggeli, A.; Breu, V.; Bur, D.; Fischli, W.; Gueller, R.; Hirth, G.; Maerki, H.-P.; Mueller, M.; Oefner, C.; Stadler, H.; Vieira, E.; Wilhelm, M.; Wostl, W. (F. Hoffmann-La Roche AG); New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency. EP 0863875; JP 1999500447; WO 9709311 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
31009 |
1-iodo-4-methoxybenzene; 4-iodophenyl methyl ether
|
696-62-8 |
C7H7IO |
详情 | 详情
|
(III) |
31010 |
4-(1-benzyl-4-methyl-4-piperidinyl)phenyl methyl ether; 1-benzyl-4-(4-methoxyphenyl)-4-methylpiperidine
|
|
C20H25NO |
详情 |
详情
|
(IV) |
31011 |
4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)phenyl methyl ether; 1-benzyl-4-(4-methoxyphenyl)-1,2,3,6-tetrahydropyridine
|
|
C19H21NO |
详情 |
详情
|
(V) |
31012 |
(3R,4R)-1-benzyl-4-(4-methoxyphenyl)-3-piperidinol
|
|
C19H23NO2 |
详情 |
详情
|
(VI) |
31013 |
(3R,4R)-1-benzyl-4-(4-hydroxyphenyl)-3-piperidinol
|
|
C18H21NO2 |
详情 |
详情
|
(VII) |
31014 |
(3R,4R)-4-(4-hydroxyphenyl)-3-piperidinol
|
|
C11H15NO2 |
详情 |
详情
|
(VIII) |
31015 |
tert-butyl (3R,4R)-3-hydroxy-4-(4-hydroxyphenyl)-1-piperidinecarboxylate
|
|
C16H23NO4 |
详情 |
详情
|
(IX) |
31016 |
1-[(3-chloropropoxy)methyl]-2-methoxybenzene; 2-[(3-chloropropoxy)methyl]phenyl methyl ether
|
|
C11H15ClO2 |
详情 |
详情
|
(X) |
31017 |
2-(chloromethyl)phenyl methyl ether; 1-(chloromethyl)-2-methoxybenzene
|
7035-02-1 |
C8H9ClO |
详情 | 详情
|
(XI) |
19490 |
3-chloro-1-propanol
|
627-30-5 |
C3H7ClO |
详情 | 详情
|
(XII) |
31018 |
tert-butyl (3R,4R)-3-hydroxy-4-(4-[3-[(2-methoxybenzyl)oxy]propoxy]phenyl)-1-piperidinecarboxylate
|
|
C27H37NO6 |
详情 |
详情
|
(XIII) |
31019 |
7-(bromomethyl)quinoline
|
|
C10H8BrN |
详情 |
详情
|
(XIV) |
31020 |
tert-butyl (3R,4R)-4-(4-[3-[(2-methoxybenzyl)oxy]propoxy]phenyl)-3-(7-quinolinylmethoxy)-1-piperidinecarboxylate
|
|
C37H44N2O6 |
详情 |
详情
|
(XV) |
31021 |
tert-butyl (3R,4R)-4-(4-[3-[(2-methoxybenzyl)oxy]propoxy]phenyl)-3-(1,2,3,4-tetrahydro-7-quinolinylmethoxy)-1-piperidinecarboxylate
|
|
C37H48N2O6 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(I) Horner-Emmons reaction of 1-benzyl-4-piperidone (I) with diethyl cyanomethylphosphonate (II) in the presence of K2CO3 provided the piperidinilydeneacetonitrile (III). Reduction of the double bond of (III) with magnesium in MeOH yielded the saturated nitrile (IV), which was further reduced to amine (V) using LiAlH4. Treatment of 6-phenyl-3-pyridazinone (VI) with POCl3 gave the chloropyridazine (VII). This was coupled with diamine (V) in the presence of ammonium chloride in refluxing butanol to furnish the title pyridazinamine, which was finally converted to the dihydrochloride salt.
【1】
Rival, Y.M.; Bourguignon, J.-J.; Contreras, J.-M.; Chayer, S.; Wermuth, C.G.; Aminopyridazines as acetylcholinesterase inhibitors. J Med Chem 1999, 42, 4, 730.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
10045 |
Diethyl cyanomethylphosphonate
|
2537-48-6 |
C6H12NO3P |
详情 | 详情
|
(III) |
31448 |
2-(1-benzyl-4-piperidinylidene)acetonitrile
|
|
C14H16N2 |
详情 |
详情
|
(IV) |
31449 |
2-(1-benzyl-4-piperidinyl)acetonitrile
|
|
C14H18N2 |
详情 |
详情
|
(V) |
17606 |
2-(1-benzyl-4-piperidinyl)-1-ethanamine; 2-(1-benzyl-4-piperidinyl)ethylamine
|
|
C14H22N2 |
详情 |
详情
|
(VI) |
31450 |
6-phenyl-3(2H)-pyridazinone
|
|
C10H8N2O |
详情 |
详情
|
(VII) |
31451 |
3-chloro-6-phenylpyridazine
|
|
C10H7ClN2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) The condensation of the protected 3,5-difluoroaniline (I) with 1-benzyl-4-piperidone (II) by means of BuLi in THF gives 4-(1-benzyl-4-hydroxypiperidin-4-yl)-3,5-difluoroaniline (III), which is dehydrated with refluxing conc. HCl to yield the tetrahydropyridine (IV). The reaction of (IV) with benzyl chloroformate in acetone/water affords the carbamate (V), which is cyclized with (R)-glycidyl butyrate (VI) by means of BuLi in THF to provide the oxazolidinone (VII). The condensation of (VII) with isoxazol-3-ol (VIII) by means of PPh3 and DIAD in THF gives the expected ether adduct (IX), which is debenzylated by reaction with 1-chloroethyl chloroformate in dichloromethane, yielding the free tetrahydropyridine derivative (X). The condensation of (X) with (S)-2,3-O-isopropylideneglyceric acid (XI) by means of DEC or DCC and TEA in dichloromethane affords the corresponding acyl tetrahydropyridine (XII), which is finally deprotected with HCl in THF to provide the target dihydroxy compound.
【1】
Gravestock, M.B. (AstraZeneca plc); Oxazolidinone derivs., process for their preparation and pharmaceutical compsns. containing them. EP 1082323; JP 2002517498; WO 9964417 .
|
【2】
Gravestock, M.B.; Warren, K.E.H.; Ennis, D.S.; Currie, A.C.; Ainge, D. (AstraZeneca AB; AstraZeneca plc); Chemical processes and intermedies. WO 0140236 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
59481 |
1-(3,5-difluorophenyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine
|
|
C12H19F2NSi2 |
详情 |
详情
|
(II) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(III) |
59482 |
4-(4-amino-2,6-difluorophenyl)-1-benzyl-4-piperidinol
|
|
C18H20F2N2O |
详情 |
详情
|
(IV) |
59483 |
4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenylamine; 4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluoroaniline
|
|
C18H18F2N2 |
详情 |
详情
|
(V) |
59484 |
benzyl 4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenylcarbamate
|
|
C26H24F2N2O2 |
详情 |
详情
|
(VI) |
17017 |
(2S)oxiranylmethyl butyrate
|
|
C7H12O3 |
详情 |
详情
|
(VII) |
59485 |
(5R)-3-[4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
|
|
C22H22F2N2O3 |
详情 |
详情
|
(VIII) |
59486 |
3-isoxazolol
|
|
C3H3NO2 |
详情 |
详情
|
(IX) |
59487 |
(5R)-3-[4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenyl]-5-[(3-isoxazolyloxy)methyl]-1,3-oxazolidin-2-one
|
|
C25H23F2N3O4 |
详情 |
详情
|
(X) |
59488 |
(5R)-3-[3,5-difluoro-4-(1,2,3,6-tetrahydro-4-pyridinyl)phenyl]-5-[(3-isoxazolyloxy)methyl]-1,3-oxazolidin-2-one
|
|
C18H17F2N3O4 |
详情 |
详情
|
(XI) |
59489 |
(4S)-2,2-dimethyl-1,3-dioxolane-4-carboxylic acid
|
|
C6H10O4 |
详情 |
详情
|
(XII) |
59490 |
(5R)-3-[4-(1-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]carbonyl}-1,2,3,6-tetrahydro-4-pyridinyl)-3,5-difluorophenyl]-5-[(3-isoxazolyloxy)methyl]-1,3-oxazolidin-2-one
|
|
C24H25F2N3O7 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(XII) Addition of 4-fluorophenylmagnesium bromide (XIII) to 1-benzyl-4-piperidinone (XII) afforded carbinol (XIV), which was dehydrated to the tetrahydropyridine (XV) by treatment with p-toluenesulfonic acid in refluxing toluene. Hydrogenation of the olefin (XV) with concomitant benzyl group hydrogenolysis gave 4-(4-fluorophenyl)piperidine (XVI) (1). This compound was also obtained by catalytic hydrogenation of the commercially available 4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridine (XVII). Alkylation of piperidine (XVI) with N-(3-bromopropyl)phthalimide (XVIII) provided adduct (XIX), which was subjected to hydrazinolysis in refluxing MeOH to furnish the primary amine (XX). Deprotonation of oxazolidine (IX) with n-butyllithium in THF at -78 C, followed by condensation with p-nitrophenyl chloroformate, gave the p-nitrophenoxycarbonyl derivative (XXI). This was finally coupled with amine (XX) to furnish the title carboxamide.
【1】
Tian, D.; Jeon, Y.; Lagu, B.; et al.; De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailability. J Med Chem 2000, 43, 15, 2775.
|
【2】
Broten, T.P.; Nichtberger, S.A.; Siegl, P.K.S. (Merck & Co., Inc.); Combination therapy for the treatment of benign prostatic hyperplasia. WO 9948530 .
|
【3】
Marzabadi, M.R.; Wong, W.C.; Gluchowski, C.; Tian, D.; Nagarathnam, D.; Lagu, B.; Dhar, T.G.M.; Jeon, Y.T. (Synaptic Pharmaceutical Corp.); Heterocyclic substd. piperidines and uses thereof. EP 0988295; WO 9857940 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
43324 |
(4S,5S)-4-(3,4-difluorophenyl)-5-methyl-1,3-oxazolidin-2-one
|
|
C10H9F2NO2 |
详情 |
详情
|
(XII) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(XIII) |
13643 |
4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide |
352-13-6 |
C6H4BrFMg |
详情 | 详情
|
(XIV) |
15722 |
1-benzyl-4-(4-fluorophenyl)-4-piperidinol
|
|
C18H20FNO |
详情 |
详情
|
(XV) |
43327 |
1-benzyl-4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridine
|
|
C18H18FN |
详情 |
详情
|
(XVI) |
39299 |
4-(4-fluorophenyl)piperidine
|
37656-48-7 |
C11H14FN |
详情 | 详情
|
(XVII) |
23465 |
4-(4-fluorophenyl)-1,2,3,6-tetrahydropyridine
|
1978-59-2 |
C11H12FN |
详情 | 详情
|
(XVIII) |
15216 |
N-(3-Bromopropyl)phthalimide; 2-(3-bromopropyl)-1H-isoindole-1,3(2H)-dione
|
5460-29-7 |
C11H10BrNO2 |
详情 | 详情
|
(XIX) |
39300 |
2-[3-[4-(4-fluorophenyl)-1-piperidinyl]propyl]-1H-isoindole-1,3(2H)-dione
|
|
C22H23FN2O2 |
详情 |
详情
|
(XX) |
39302 |
3-[4-(4-fluorophenyl)-1-piperidinyl]propylamine; 3-[4-(4-fluorophenyl)-1-piperidinyl]-1-propanamine
|
|
C14H21FN2 |
详情 |
详情
|
(XXI) |
43328 |
4-nitrophenyl (4S,5S)-4-(3,4-difluorophenyl)-5-methyl-2-oxo-1,3-oxazolidine-3-carboxylate
|
|
C17H12F2N2O6 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(I) Horner-Emmons reaction of 1-benzyl-4-piperidone (I) with triethyl 4-phosphonocrotonate (II) afforded the (piperidinylidene)butenoate (III). Catalytic hydrogenation of the double bond of (III) with concomitant N-debenzylation yielded the piperidinylbutanoate (IV). After reprotection as the N-benzyl derivative (V), reduction of the ester function of (V) using LiAlH4 gave alcohol (VI), which was further converted to mesylate (VII). Displacement of the mesylate group of (VII) with diethylamine produced diamine (VIII). The N-benzyl group of (VIII) was then deprotected by transfer hydrogenation to furnish piperidine (IX). The chloroacetyl derivative (XI) was prepared by acylation of iminodibenzyl (X) with chloroacetyl chloride. Chloride (XI) was finally condensed with piperidine (IX) in the presence of Na2CO3 and NaI to afford the title compound.
【1】
Maiorana, S.; Colibretti, M.L.; Terni, P.; Imbimbo, B.P.; Mandelli, G.R.; Lamperti, G.; Synthesis of new cardioselective M2 muscarinic receptor antagonists. Chem Pharm Bull 2000, 48, 11, 1611.
|
【2】
Imbimbo, B.P.; Mandelli, G.R.; Terni, P.M.L.; Maiorana, S. (Mediolanum Farmaceutici); Selective M2 muscarinic receptor antagonists having 5H-dibenz[b,f]azepine structure. WO 0102386 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(II) |
22705 |
ethyl (E)-4-(diethoxyphosphoryl)-2-butenoate
|
|
C10H19O5P |
详情 |
详情
|
(III) |
48038 |
ethyl (E)-4-(1-benzyl-4-piperidinylidene)-2-butenoate
|
|
C18H23NO2 |
详情 |
详情
|
(IV) |
48039 |
ethyl 4-(4-piperidinyl)butanoate
|
|
C11H21NO2 |
详情 |
详情
|
(V) |
48040 |
ethyl 4-(1-benzyl-4-piperidinyl)butanoate
|
|
C18H27NO2 |
详情 |
详情
|
(VI) |
48041 |
4-(1-benzyl-4-piperidinyl)-1-butanol
|
|
C16H25NO |
详情 |
详情
|
(VII) |
48042 |
4-(1-benzyl-4-piperidinyl)butyl methanesulfonate
|
|
C17H27NO3S |
详情 |
详情
|
(VIII) |
48043 |
4-(1-benzyl-4-piperidinyl)-N,N-diethyl-1-butanamine; N-[4-(1-benzyl-4-piperidinyl)butyl]-N,N-diethylamine
|
|
C20H34N2 |
详情 |
详情
|
(IX) |
31153 |
N,N-diethyl-N-[4-(4-piperidinyl)butyl]amine; N,N-diethyl-4-(4-piperidinyl)-1-butanamine
|
|
C13H28N2 |
详情 |
详情
|
(X) |
47619 |
Iminostilbene; 5H-dibenzo[b,f]azepine
|
256-96-2 |
C14H11N |
详情 | 详情
|
(XI) |
48044 |
2-chloro-1-(5H-dibenzo[b,f]azepin-5-yl)-1-ethanone
|
|
C16H12ClNO |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(VIII) The aliphatic amino group of 4-aminophenethylamine (VI) was regioselectively protected as the N-Boc derivative (VII) using Boc2O. Subsequent reductive alkylation of aniline (VII) with N-benzyl-4-piperidone (VIII) afforded the anilinopiperidine (IX). The N-benzyl group of (IX) was then removed by transfer hydrogenolysis, and the resulting piperidine (X) was condensed with octyl isocyanate (XI), yielding the corresponding urea (XII). After acidic cleavage of the N-Boc protecting group of (XII), the primary amine (XIII) was condensed with the intermediate epoxide (V) to produce the amino alcohol (XIV). Final desilylation of (XIV) gave rise to the title compound.
【1】
Solvibile, W.R.; et al.; Potent, selective agonists of the human beta3-adrenergic receptor. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 35.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
52064 |
tert-butyl[4-[(2S)oxiranylmethoxy]phenoxy]diphenylsilane; tert-butyl(diphenyl)silyl 4-[(2S)oxiranylmethoxy]phenyl ether
|
|
C25H28O3Si |
详情 |
详情
|
(VI) |
18961 |
4-(2-aminoethyl)aniline; 4-(2-aminoethyl)phenylamine
|
13472-00-9 |
C8H12N2 |
详情 | 详情
|
(VII) |
18966 |
tert-butyl 4-aminophenethylcarbamate
|
|
C13H20N2O2 |
详情 |
详情
|
(VIII) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(IX) |
52065 |
tert-butyl 4-[(1-benzyl-4-piperidinyl)amino]phenethylcarbamate
|
|
C25H35N3O2 |
详情 |
详情
|
(X) |
52066 |
tert-butyl 4-(4-piperidinylamino)phenethylcarbamate
|
|
C18H29N3O2 |
详情 |
详情
|
(XI) |
52067 |
1-isocyanatooctane; octyl isocyanate
|
|
C9H17NO |
详情 |
详情
|
(XII) |
52068 |
tert-butyl 4-([1-[(octylamino)carbonyl]-4-piperidinyl]amino)phenethylcarbamate
|
|
C27H46N4O3 |
详情 |
详情
|
(XIII) |
52069 |
4-[4-(2-aminoethyl)anilino]-N-octyl-1-piperidinecarboxamide
|
|
C22H38N4O |
详情 |
详情
|
(XIV) |
52070 |
4-[4-(2-[[(2S)-3-(4-[[tert-butyl(diphenyl)silyl]oxy]phenoxy)-2-hydroxypropyl]amino]ethyl)anilino]-N-octyl-1-piperidinecarboxamide
|
|
C47H66N4O4Si |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(XI) 4-Aminophenethylamine (IX) was selectively protected at the aliphatic amino group by means of Boc2O to afford (X). Reductive alkylation of aniline (X) with N-benzyl-4-piperidone (XI) in the presence of NaBH(OAc)3 furnished the secondary amine (XII). Subsequent N-benzyl group cleavage in (XI) by transfer hydrogenolysis gave rise to diamine (XIII), which was further converted to urea (XV) by coupling with isocyanate (XIV). The N-Boc group of (XV) was then cleaved by means of formic acid, yielding amine (XVI). The title compound was then obtained by condensation of amine (XVI) with epoxide (VIII), followed by removal of the N-Boc and silyl protecting groups.
【1】
Mulvey, R.; Ashwell, M.A.; Solvibile, W.R. Jr.; Han, S.; Tillet, J.; Largis, E.; 4-Aminopiperidine ureas as potent selective agonists of the human beta3-adrenergic receptor. Bioorg Med Chem Lett 2001, 11, 24, 3123.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
59665 |
tert-butyl 2-{[tert-butyl(diphenyl)silyl]oxy}-5-[(2S)oxiranylmethoxy]phenyl(methylsulfonyl)carbamate
|
|
C31H39NO7SSi |
详情 |
详情
|
(IX) |
18961 |
4-(2-aminoethyl)aniline; 4-(2-aminoethyl)phenylamine
|
13472-00-9 |
C8H12N2 |
详情 | 详情
|
(X) |
18966 |
tert-butyl 4-aminophenethylcarbamate
|
|
C13H20N2O2 |
详情 |
详情
|
(XI) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(XII) |
52065 |
tert-butyl 4-[(1-benzyl-4-piperidinyl)amino]phenethylcarbamate
|
|
C25H35N3O2 |
详情 |
详情
|
(XIII) |
52066 |
tert-butyl 4-(4-piperidinylamino)phenethylcarbamate
|
|
C18H29N3O2 |
详情 |
详情
|
(XIV) |
59666 |
1,4-difluoro-2-(isocyanatomethyl)benzene; 2,5-difluorobenzyl isocyanate
|
|
C8H5F2NO |
详情 |
详情
|
(XV) |
59667 |
tert-butyl 4-[(1-{[(2,5-difluorobenzyl)amino]carbonyl}-4-piperidinyl)amino]phenethylcarbamate
|
|
C26H34F2N4O3 |
详情 |
详情
|
(XVI) |
59668 |
4-[4-(2-aminoethyl)anilino]-N-(2,5-difluorobenzyl)-1-piperidinecarboxamide
|
|
C21H26F2N4O |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(II) The cyclization of (3R)-N-Boc-3-cyclohexyl-D-serine (I) with 1-benzylpiperidin-4-one (II), benzyl isonitrile (III) and butylamine (IV) in refluxing methanol gives the piperidine derivative (V), whose Boc group is removed by treatment with TFA in dichloromethane, yielding compound (VI). The cyclization of (VI) by means of AcOH in hot toluene affords the spiro[piperazine-2,4'-piperidine] derivative (VII), which is hydrogenated in methanol over palladium hydroxide on carbon to cleave the benzyl protecting group and provide the unprotected spiro derivative (VIII). Finally, this compound is reductocondensed with 4-(4-formylphenoxy)benzoic acid (IX) by means of sodium triacetoxyborohydride in DMF/AcOH to give the target spiro[piperazine-2,4'-piperidine] derivative.
【1】
Shibayama, S.; Hamano, S.; Takaoka, Y.; Habashita, H. (Ono Pharmaceutical Co., Ltd.); Triazaspiro[5.5]undecane derivs. and drugs containing the same as the active ingredient. EP 1378510; WO 0274770 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
64663 |
(2R,3R)-2-[(tert-butoxycarbonyl)amino]-3-cyclohexyl-3-hydroxypropanoic acid
|
|
C14H25NO5 |
详情 |
详情
|
(II) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(III) |
16730 |
1-(Isocyanatomethyl)benzene; Benzyl Isocyanate
|
3173-56-6 |
C8H7NO |
详情 | 详情
|
(IV) |
39041 |
butylamine; 1-butanamine
|
109-73-9 |
C4H11N |
详情 | 详情
|
(V) |
64664 |
tert-butyl (1R)-2-[{1-benzyl-4-[(benzylamino)carbonyl]-4-piperidinyl}(butyl)amino]-1-[(R)-cyclohexyl(hydroxy)methyl]-2-oxoethylcarbamate
|
|
C38H56N4O5 |
详情 |
详情
|
(VI) |
64665 |
4-[[(2R,3R)-2-amino-3-cyclohexyl-3-hydroxypropanoyl](butyl)amino]-N,1-dibenzyl-4-piperidinecarboxamide
|
|
C33H48N4O3 |
详情 |
详情
|
(VII) |
64666 |
(3R)-9-benzyl-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione
|
|
C26H39N3O3 |
详情 |
详情
|
(VIII) |
64667 |
(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-1,4,9-triazaspiro[5.5]undecane-2,5-dione
|
|
C19H33N3O3 |
详情 |
详情
|
(IX) |
64668 |
4-(4-formylphenoxy)benzoic acid
|
|
C14H10O4 |
详情 |
详情
|